Like other weight loss injections, the medication will be supplied in a pre-filled pen designed for self-administration
The short answer is that weight loss injections do not typically cause serious heart problems in most patients, and emerging evidence suggests they may actually protect against cardiovascular events in specific populations
Medical Disclaimer: Retatrutide is an investigational drug and is not yet FDA-approved
This will save you time and hassle when going through security
The New England journal of medicine 2023 PMID: 37366315 Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials Giblin K, Kaplan LM, Somers VK, et al
Dietary cytidine (5')-diphosphocholine supplementation protects against development of memory deficits in aging rats